Medicine
Klisyri 1% ointment
Klisyri 1% ointment is a prescription medicine containing Tirbanibulin for topical use, marketed by Almirall, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not refrigerate or freeze. Store at 20°C-25°C (68°F-77°F), excursions…
Key facts
- Active ingredient (INN)
- Tirbanibulin
- Brand
- Klisyri
- Strength
- 1%
- Dosage form
- Ointment
- Route
- Topical
- Packs
- 5 packets
- Marketing authorisation holder
- Almirall
- Manufacturer
- Almirall
- Origin register
- US FDA, United States
- Storage
- Do not refrigerate or freeze. Store at 20°C-25°C (68°F-77°F), excursions permitted to 15°C-30°C (59°F-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D06BX03 Tirbanibulin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 December 2020
- Identifiers
- RxCUI 2471095, 2471100DailyMed set ID 589c8de8-b773-4d47-b60c-48471806ccccNDC 16110-391Application NDA213189
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Tirbanibulin is a microtubule inhibitor indicated for the topical field treatment of actinic keratosis on the face or scalp. It is available as ointment for topical use. MedsAcross supplies Tirbanibulin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TirbanibulinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Klisyri prescribing information (Almirall) · U.S. National Library of Medicine, DailyMed
- Klisyri: European public assessment report (EPAR) · European Medicines Agency
Need Klisyri 1% ointment for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.